STAAR Surgical Financials
| STAA Stock | USD 23.97 0.22 0.91% |
STAAR |
Please note, the presentation of STAAR Surgical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STAAR Surgical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STAAR Surgical's management manipulating its earnings.
STAAR Surgical Stock Summary
STAAR Surgical competes with ResMed, West Pharmaceutical, ICU Medical, Merit Medical, and Microbot Medical. STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Staar Surgical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 692 people.Specialization | Healthcare, Medical Instruments & Supplies |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US8523123052 |
| CUSIP | 852312305 |
| Location | California; U.S.A |
| Business Address | 25651 Atlantic Ocean |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.staar.com |
| Phone | 626 303 7902 |
| Currency | USD - US Dollar |
STAAR Surgical Key Financial Ratios
| Return On Equity | 0.054 | ||||
| Return On Asset | 0.0339 | ||||
| Target Price | 39.41 | ||||
| Beta | 0.62 |
STAAR Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining STAAR Surgical's current stock value. Our valuation model uses many indicators to compare STAAR Surgical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across STAAR Surgical competition to find correlations between indicators driving STAAR Surgical's intrinsic value. More Info.STAAR Surgical is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for STAAR Surgical is roughly 1.59 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the STAAR Surgical's earnings, one of the primary drivers of an investment's value.STAAR Surgical Systematic Risk
STAAR Surgical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. STAAR Surgical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on STAAR Surgical correlated with the market. If Beta is less than 0 STAAR Surgical generally moves in the opposite direction as compared to the market. If STAAR Surgical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one STAAR Surgical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of STAAR Surgical is generally in the same direction as the market. If Beta > 1 STAAR Surgical moves generally in the same direction as, but more than the movement of the benchmark.
About STAAR Surgical Financials
What exactly are STAAR Surgical Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include STAAR Surgical's income statement, its balance sheet, and the statement of cash flows. Potential STAAR Surgical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although STAAR Surgical investors may use each financial statement separately, they are all related. The changes in STAAR Surgical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on STAAR Surgical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.STAAR Surgical January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of STAAR Surgical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of STAAR Surgical. We use our internally-developed statistical techniques to arrive at the intrinsic value of STAAR Surgical based on widely used predictive technical indicators. In general, we focus on analyzing STAAR Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build STAAR Surgical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 11.94 | |||
| Value At Risk | (4.64) | |||
| Potential Upside | 3.77 |
Complementary Tools for STAAR Stock analysis
When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |